title: Should physicians withhold highly active antiretroviral therapies from HIV-AIDS patients who are thought to be poorly adherent to treatment?
authors.forename: S
authors.initials: S
authors.lastname: Sollitto
authors.forename: M
authors.initials: M
authors.lastname: Mehlman
authors.forename: S
authors.initials: S
authors.lastname: Youngner
authors.forename: M M
authors.initials: MM
authors.lastname: Lederman
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000706:statistics & numerical data*; D015658:HIV Infections / Q000188:drug therapy*; D006291:Health Policy; D006801:Humans; D010819:Physician's Role; D016312:Treatment Refusal
chemical_list: D019380:Anti-HIV Agents